CVE:SVASernova Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$0.20 +0.01 (+5.26 %) (As of 05/29/2020 04:00 PM ET) Add Compare Share Today's RangeC$0.19Now: C$0.20▼C$0.2050-Day RangeC$0.13MA: C$0.16▼C$0.2052-Week RangeC$0.10Now: C$0.20▼C$0.29Volume324,900 shsAverage Volume321,630 shsMarket CapitalizationC$39.19 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsHeadlinesOptions ChainSocial Media Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch and associated technologies, including therapeutic cells and local immune protection. The company is developing a Cell Pouch system that is in Phase I/II clinical trial for the treatment of type-1 diabetes. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells for the treatment of chronic diseases, such as hemophilia A and thyroid diseases. Sernova Corp. is headquartered in London, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Sernova. Previous Next 2.3 Community Rank Outperform VotesSernova has received 42 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSernova has received 50 “underperform” votes. (Add your “underperform” vote.)Community SentimentSernova has received 54.35% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Sernova and other stocks. Vote “Outperform” if you believe SVA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SVA will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSernova does not currently pay a dividend.Dividend GrowthSernova does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sernova insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Sernova are expected to decrease by -100.00% in the coming year, from C$0.02 to C$0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Sernova is -7.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sernova is -7.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSernova has a P/B Ratio of 10.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.46 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolCVE:SVA Previous Symbol CUSIPN/A CIKN/A Webwww.sernova.com Phone+1-519-8585184Debt Debt-to-Equity Ratio1.74 Current Ratio8.28 Quick Ratio7.04Price-To-Earnings Trailing P/E RatioN/A Forward P/E Ratio9.64 P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.02 per share Price / Cash Flow12.67 Book ValueC$0.02 per share Price / Book10.53Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares195,945,000Market CapC$39.19 million Next Earnings Date6/26/2020 (Estimated) OptionableOptionable TSXV:SVA Rates by TradingView Receive SVA News and Ratings via Email Sign-up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter. Sernova (CVE:SVA) Frequently Asked Questions How has Sernova's stock been impacted by COVID-19 (Coronavirus)? Sernova's stock was trading at C$0.15 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SVA shares have increased by 37.9% and is now trading at C$0.20. View which stocks have been most impacted by Coronavirus. When is Sernova's next earnings date? Sernova is scheduled to release its next quarterly earnings announcement on Friday, June 26th 2020. View our earnings forecast for Sernova. How were Sernova's earnings last quarter? Sernova Corp. (CVE:SVA) issued its earnings results on Thursday, March, 19th. The company reported ($0.01) earnings per share for the quarter. View Sernova's earnings history. Has Sernova been receiving favorable news coverage? News articles about SVA stock have trended extremely negative recently, InfoTrie reports. The research firm rates the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Sernova earned a media sentiment score of -5.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutSernova. Who are some of Sernova's key competitors? Some companies that are related to Sernova include Yourgene Health (YGEN), Senseonics (SENS), Palatin Technologies (PTN), MaxCyte (MXCT), Oncosil Medical (OSL), Lexagene (LXG), Oncimmune (ONC), Genedrive (GDR), SQI Diagnostics (SQD), BARD1 Life Sciences (BD1), GeneNews (GEN), Deepmatter Group (DMTR), Imagion Biosys (IBX), LED Medical Diagnostics (LMD) and Cambridge Cognition (COG). View all competitors. What other stocks do shareholders of Sernova own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sernova investors own include VelocityShares 3x Long Gold ETN linked to the S&P GSCI Gold Index (UGLD), Northrop Grumman (NOC), Nemaska Lithium (NMX), Intercept Pharmaceuticals (ICPT), BMO REX MicroSectors FANG Index 3X Leveraged ETN (FNGU), Cognizant Technology Solutions (CTSH), CorMedix (CRMD) and Canarc Resource (CCM). What is Sernova's stock symbol? Sernova trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SVA." How do I buy shares of Sernova? Shares of SVA and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Sernova's stock price today? One share of SVA stock can currently be purchased for approximately C$0.20. How big of a company is Sernova? Sernova has a market capitalization of C$39.19 million. What is Sernova's official website? The official website for Sernova is www.sernova.com. How can I contact Sernova? Sernova's mailing address is 700 Collip Cir Suite 114, LONDON, ON N6G 4X8, Canada. The company can be reached via phone at +1-519-8585184. This page was last updated on 5/30/2020 by MarketBeat.com Staff
